Candida albicans and Candida glabrata : global priority pathogens
Microbiology and Molecular Biology Reviews · 27.06.2024 · 88 (2)
DOI: 10.1128/mmbr.00021-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiology and Molecular Biology Reviews, erschienen am 27.06.2024. Verfasst von Myrto Katsipoulaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Pathogenicity Mechanisms, Hans Knoell Institute, Jena, Germany. Hauptthemen laut MEDLINE: Candida glabrata, Candida albicans, Drug Resistance, Fungal, Candidiasis. Die Arbeit wurde bisher 180-mal zitiert (Crossref) und nennt 534 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Bundesministerium für Bildung und Forschung (BMBF), Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter.
Abstract (Originalsprache)
A significant increase in the incidence of Candida -mediated infections has been observed in the last decade, mainly due to rising numbers of susceptible individuals. Recently, the World Health Organization published its first fungal pathogen priority list, with Candida species listed in medium, high, and critical priority categories. This review is a synthesis of information and recent advances in our understanding of two of these species —Candida albicans and Candida glabrata . Of these, C. albicans is the most common cause of candidemia around the world and is categorized as a critical priority pathogen. C. glabrata is considered a high-priority pathogen and has become an increasingly important cause of candidemia in recent years. It is now the second most common causative agent of candidemia in many geographical regions. Despite their differences and phylogenetic divergence, they are successful as pathogens and commensals of humans. Both species can cause a broad variety of infections, ranging from superficial to potentially lethal systemic infections. While they share similarities in certain infection strategies, including tissue adhesion and invasion, they differ significantly in key aspects of their biology, interaction with immune cells, host damage strategies, and metabolic adaptations. Here we provide insights on key aspects of their biology, epidemiology, commensal and pathogenic lifestyles, interactions with the immune system, and antifungal resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Pathogenicity Mechanisms, Hans Knoell Institute, Jena, Germany.
- MRC Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.
- Institute of Microbiology, Friedrich Schiller University, Jena, Germany.
ORCID-Profile: Myrto Katsipoulaki, Mark H T Stappers, Dhara Malavia-Jones, Sascha Brunke, Bernhard Hube, Neil A R Gow
Förderung
- Bundesministerium für Bildung und Forschung (BMBF)
- Medical Research Council Centre for Medical Mycology (MRC CMM)
- University of Exeter
- Wellcome Trust (WT)
- UKRI | Medical Research Council (MRC)
- National Institute for Health and Care Research Exeter Biomedical Research Centre
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Katsipoulaki, M., Stappers, M. H. T., Malavia-Jones, D., Brunke, S., Hube, B., & Gow, N. A. R. (2024). Candida albicans and Candida glabrata : global priority pathogens. Microbiology and Molecular Biology Reviews, 88(2). https://doi.org/10.1128/mmbr.00021-23
Vancouver
Katsipoulaki M, Stappers MHT, Malavia-Jones D, Brunke S, Hube B, Gow NAR. Candida albicans and Candida glabrata : global priority pathogens. Microbiology and Molecular Biology Reviews. 2024;88(2). doi:10.1128/mmbr.00021-23
BibTeX
@article{Katsipoulaki2024,
author = {Katsipoulaki, Myrto and Stappers, Mark H T and Malavia-Jones, Dhara and Brunke, Sascha and Hube, Bernhard and Gow, Neil A R},
title = {Candida albicans and Candida glabrata : global priority pathogens},
journal = {Microbiology and Molecular Biology Reviews},
year = {2024},
volume = {88},
number = {2},
doi = {10.1128/mmbr.00021-23}
}
EUVIMED